Oscar Health (OSCR) Net Income towards Common Stockholders (2020 - 2026)

Oscar Health (OSCR) has 7 years of Net Income towards Common Stockholders data on file, last reported at $679.0 million in Q1 2026.

• Quarterly Net Income towards Common Stockholders rose 146.46% year-over-year to $679.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$39.4 million (down 131.73% YoY) and the FY2025 annual result came in at -$442.9 million, down 1795.58% from the prior year.
• Net Income towards Common Stockholders grew to $679.0 million in Q1 2026, from -$352.4 million in the prior quarter.
• In the past five years, Net Income towards Common Stockholders ranged from a high of $679.0 million in Q1 2026 to a low of -$352.4 million in Q4 2025.
• A 5-year average of -$36.3 million and a median of -$77.3 million in 2022 frame the typical range for Net Income towards Common Stockholders.
• Annual changes were most pronounced in 2024 — Net Income towards Common Stockholders soared 547.87% — and 2025, when it slumped 505.76%.
• Tracing OSCR's Net Income towards Common Stockholders over 5 years: stood at -$226.6 million in 2022, then jumped by 33.86% to -$149.8 million in 2023, then fell by 2.3% to -$153.3 million in 2024, then plunged by 129.92% to -$352.4 million in 2025, then soared by 292.67% to $679.0 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at $679.0 million (Q1 2026), -$352.4 million (Q4 2025), and -$137.5 million (Q3 2025), per Business Quant data.